Impact of Obesity on Vaccination to SARS-CoV-2
To combat the immense toll on global public health induced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), new vaccines were developed. While these vaccines have protected the populations who received them from severe SARS-CoV-2 infection, the effectiveness and durability of these v...
Main Authors: | Michaella-Jana C. Nasr, Elizabeth Geerling, Amelia K. Pinto |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-06-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2022.898810/full |
Similar Items
-
A comprehensive review of SARS-CoV-2 vaccines: Pfizer, Moderna & Johnson & Johnson
by: Rikin Patel, et al.
Published: (2022-01-01) -
Tolerance for three commonly administered COVID-19 vaccines by healthcare professionals
by: Stacy E. F. Melanson, et al.
Published: (2022-09-01) -
Anti-SARS-CoV-2 IgG against the S Protein: A Comparison of BNT162b2, mRNA-1273, ChAdOx1 nCoV-2019 and Ad26.COV2.S Vaccines
by: Joanna Szczepanek, et al.
Published: (2022-01-01) -
Ischemic retinal events after COVID-19 vaccination
by: Aaron Zachariah Priluck, et al.
Published: (2022-06-01) -
Myocarditis Following COVID-19 Vaccination: Cardiac Imaging Findings in 118 Studies
by: Pedram Keshavarz, et al.
Published: (2022-07-01)